Skip to content
10-Q

Quarterly Report

HASCO Medical, Inc.

0001161697-14-000243

← back to feed
Filed
Jun 12, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · May 31, 2014 996.94M sh
Long Term Debt Q3 2013 · Sep 30, 2013 $6.17M
Long Term Debt Q3 2013 · Dec 31, 2012 $6.39M
Stockholders Equity Q3 2013 · Sep 30, 2013 $2.25M
Stockholders Equity Q3 2013 · Dec 31, 2012 $1.69M
Stockholders Equity restated Q3 2013 · Sep 30, 2012 $1.88M
Current Liabilities Q3 2013 · Sep 30, 2013 $20.11M
Current Liabilities Q3 2013 · Dec 31, 2012 $18.45M
Current Liabilities restated Q3 2013 · Sep 30, 2012 $18.86M
Total Liabilities Q3 2013 · Sep 30, 2013 $27.16M
Total Liabilities Q3 2013 · Dec 31, 2012 $25.37M
Total Liabilities restated Q3 2013 · Sep 30, 2012 $26.16M
Current Assets Q3 2013 · Sep 30, 2013 $20.38M
Current Assets Q3 2013 · Dec 31, 2012 $18.63M
Current Assets restated Q3 2013 · Sep 30, 2012 $19.04M
Total Assets Q3 2013 · Sep 30, 2013 $29.4M
Total Assets Q3 2013 · Dec 31, 2012 $27.07M
Total Assets restated Q3 2013 · Sep 30, 2012 $28.05M
Shares Diluted Q3 2013 · Sep 30, 2012 984.66M sh
Capex restated Q3 2013 · Sep 30, 2012 $418.69K
Operating Cash Flow restated Q3 2013 · Sep 30, 2012 −$27.23K
Cash And Equivalents Q3 2013 · Sep 30, 2012 $320.75K
Cash And Equivalents Q3 2013 · Dec 31, 2011 $212.46K
Sga Expense restated Q3 2013 · Sep 30, 2012 $2.23M
Sga Expense restated Q3 2013 · Sep 30, 2012 $5.84M
Net Income restated Q3 2013 · Sep 30, 2012 −$12.56K
Net Income restated Q3 2013 · Sep 30, 2012 $280.34K
Operating Income restated Q3 2013 · Sep 30, 2012 $209.89K
Operating Income restated Q3 2013 · Sep 30, 2012 $934.36K
Gross Profit restated Q3 2013 · Sep 30, 2012 $3.66M
Gross Profit restated Q3 2013 · Sep 30, 2012 $9.85M
Cost Of Revenue restated Q3 2013 · Sep 30, 2012 $14.23M
Cost Of Revenue restated Q3 2013 · Sep 30, 2012 $36.07M
Revenue restated Q3 2013 · Sep 30, 2012 $17.89M
Revenue restated Q3 2013 · Sep 30, 2012 $45.91M